ZymoChem discloses $25.1m in equity financing
The biomanufacturing company reported equity sales separately from an additional share exchange.
ZymoChem disclosed $25,104,046 in equity sales in an October 2 SEC filing, against a total offering of $34,181,603. The first sale took place on September 18, and 19 investors were listed without names.
The notice separately reported an exchange of 1,063,848 common shares for 32,650,392 preferred shares. That exchange had an undetermined value and was reported in addition to the equity-sales amount.
ZymoChem uses carbon-conserving microbes to turn renewable feedstocks into materials. Its products include BAYSE, a bio-based superabsorbent for hygiene applications.